After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Medical Devices industry segment. The current market capitalization of Conmed Corp is $1.37B. A total of 0.85 million shares were traded on the day, compared to an average of 406.95K shares.
In the most recent transaction, Garner Todd W bought 3,500 shares of CNMD for 43.00 per share on Nov 06 ’25. In a previous transaction on Sep 12 ’25, Farkas Charles sold 2,000 shares at 53.52 per share. CNMD shares that Director owns now total 14,859.
Among the insiders who bought shares, Farkas Charles acquired of 2,000 shares on Sep 12 ’25 at a per-share price of $53.52. In another insider transaction, Garner Todd W sold 598 shares at $52.45 per share on Aug 07 ’25. Company shares held by the Executive Vice President & CFO now total 0.
Dividend
The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Conmed Corp pays an annual dividend of $0.80, resulting in a dividend yield of 1.81%, and it has a price to earnings (P/E) ratio of 21.49.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, CNMD has a high of $78.00 and a low of $42.50.
As of this writing, CNMD has an earnings estimate of $1.32 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $1.33 per share and a lower estimate of $1.31. The company reported an EPS of $1.34 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CNMD’s latest balance sheet shows that the firm has $20.85M in Cash & Short Term Investments as of fiscal 2021. There were $684.66M in debt and $196.65M in liabilities at the time. Its Book Value Per Share was $32.41, while its Total Shareholder’s Equity was $785.43M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CNMD is Buy with a score of 3.29.
